Condition
Healthy Participants
Locations
Denmark
Start date
17/08/2026
Identifiers
Trial ID EX0700-8681,
NCT number NCT07769489,
Eudract number Not Available
NCT number NCT07769489,
Eudract number Not Available
Summary
The purpose of the study is to investigate the tolerability of different injection/infusion volumes and speed compared to standard practise. The order in which the different volumes and injection speeds will be given to participants will be allocated by chance. Participants will be in this clinical study for about 1 week.
Trial Overview:
Treatment
DEVICE: Syringe Pump
Study type
INTERVENTIONAL
Trial duration
Aug 17 2026 - Dec 11 2026
Participants
100
Phase
I
Are you eligible?
Gender
Male and female
Age
18 to 64 years old
Find out how you can participate
Questions or concerns
Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.
This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.